Covered recipient · General Payments record
JACQUELINE G BLIVEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$1,896.29
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $669.68 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $366.16 | 21 |
| Amgen Inc. | $117.99 | 1 |
| Acerta Pharma LLC | $67.88 | 1 |
| GlaxoSmithKline, LLC. | $45.77 | 2 |
| ABBVIE INC. | $22.26 | 1 |
| Novo Nordisk AS | $19.43 | 1 |
| Merck Sharp & Dohme Corporation | $16.45 | 1 |
| Exact Sciences Corporation | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.26 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106777518 | CMS |
| Amgen Inc. | $117.99 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115455129 | CMS |
| AstraZeneca Pharmaceuticals LP | $67.88 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104650799 | CMS |
| Exact Sciences Corporation | $13.74 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114594305 | CMS |
| GlaxoSmithKline, LLC. | $18.73 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116606288 | CMS |
| GlaxoSmithKline, LLC. | $27.04 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116609164 | CMS |
| Lilly USA, LLC | $3.86 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135704742 | CMS |
| Lilly USA, LLC | $16.52 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135704744 | CMS |
| Lilly USA, LLC | $9.60 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135670194 | CMS |
| Lilly USA, LLC | $69.53 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135683913 | CMS |
| Lilly USA, LLC | $11.63 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135683915 | CMS |
| Lilly USA, LLC | $121.84 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135687648 | CMS |
| Lilly USA, LLC | $12.64 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135653785 | CMS |
| Lilly USA, LLC | $14.47 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135683917 | CMS |
| Lilly USA, LLC | $10.51 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135641882 | CMS |
| Lilly USA, LLC | $4.11 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135670954 | CMS |
| Lilly USA, LLC | $5.15 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135670956 | CMS |
| Lilly USA, LLC | $13.08 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135641884 | CMS |
| Lilly USA, LLC | $11.90 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135683919 | CMS |
| Lilly USA, LLC | $13.08 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135704746 | CMS |
| Lilly USA, LLC | $13.68 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135641886 | CMS |
| Lilly USA, LLC | $10.20 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135704748 | CMS |
| Lilly USA, LLC | $4.22 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135653787 | CMS |
| Lilly USA, LLC | $3.00 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135704750 | CMS |
| Lilly USA, LLC | $8.34 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135670958 | CMS |
| Lilly USA, LLC | $2.31 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135685569 | CMS |
| Lilly USA, LLC | $6.49 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135704752 | CMS |
| Merck Sharp & Dohme LLC | $16.45 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141905620 | CMS |
| Novo Nordisk Inc | $19.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550036 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.